{
    "existing research": {
        "scenario_1": {
            "persona_id": 448,
            "persona_desc": "A scientist or researcher at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen, Germany, who specializes in the production of biopharmaceuticals from plants. This person is highly skilled in the use of plants to produce complex active substances, including proteins that cannot be chemically produced. They have developed equipment to pulp plants, which is a key step in producing biopharmaceuticals. They are currently working on developing biopharmaceuticals for clinical studies, including the production of antibodies for use in vaginal gels and malaria vaccines in plants.",
            "difficulty": "existing research",
            "metric": "Berk29",
            "options": {
                "left": {
                    "A": 400,
                    "B": 400
                },
                "right": {
                    "A": 750,
                    "B": 400
                }
            },
            "thought": "As a researcher at Fraunhofer IME, I am driven by the potential of plant-based biopharmaceuticals to improve global health. While I am not motivated by maximizing my own individual gain above all else, I also don't see a significant ethical issue with either option. Both options provide me with the same amount of money (400). Option 'Right' provides the other person with significantly more money. Given that I am not sacrificing anything personally, and it allows for the potential support of research that might ultimately benefit others, I will choose 'Right'. My scientific background predisposes me to choices that maximize overall benefit.",
            "answer": "Right"
        },
        "scenario_2": {
            "persona_id": 448,
            "persona_desc": "A scientist or researcher at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen, Germany, who specializes in the production of biopharmaceuticals from plants. This person is highly skilled in the use of plants to produce complex active substances, including proteins that cannot be chemically produced. They have developed equipment to pulp plants, which is a key step in producing biopharmaceuticals. They are currently working on developing biopharmaceuticals for clinical studies, including the production of antibodies for use in vaginal gels and malaria vaccines in plants.",
            "difficulty": "existing research",
            "metric": "Berk26",
            "options": {
                "left": {
                    "A": 0,
                    "B": 800
                },
                "right": {
                    "A": 400,
                    "B": 400
                }
            },
            "thought": "As a scientist at Fraunhofer IME, my primary goal is to contribute to the advancement of biopharmaceutical production and ultimately, to public health. While I am personally invested in my work, the ethical considerations of equitable resource distribution are also important, especially when resources are available to share. In this scenario, I am presented with a choice: maximize my own gain with a significantly larger portion while leaving the other person with nothing, or share a more modest amount that also provides the other person with a meaningful benefit. \n\nGiven my position as a researcher at a publicly funded institute focused on beneficial outcomes, the slight personal sacrifice associated with the 'Right' option is outweighed by the significant advantage of sharing the resources equally. The shared resources in the 'Right' option allows both parties to move forward with their projects without leaving any party at zero. \n\nAlthough a person might think, 'I should take 800 because I deserve it,' the altruistic perspective of wanting to share the wealth with another scientist in the field, combined with the benefits of cooperation and future collaborations, make 'Right' the more appealing option.",
            "answer": "Right"
        },
        "scenario_3": {
            "persona_id": 448,
            "persona_desc": "A scientist or researcher at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen, Germany, who specializes in the production of biopharmaceuticals from plants. This person is highly skilled in the use of plants to produce complex active substances, including proteins that cannot be chemically produced. They have developed equipment to pulp plants, which is a key step in producing biopharmaceuticals. They are currently working on developing biopharmaceuticals for clinical studies, including the production of antibodies for use in vaginal gels and malaria vaccines in plants.",
            "difficulty": "existing research",
            "metric": "Berk23",
            "options": {
                "left": {
                    "A": 800,
                    "B": 200
                },
                "right": {
                    "A": 0,
                    "B": 0
                }
            },
            "thought": "As a researcher at Fraunhofer IME, my primary goal is advancing biopharmaceutical production and ensuring its accessibility for clinical studies and future applications. While I am not solely driven by personal gain, access to resources and funding is vital to continue my research and contribute to society. \n\nOption (Left) provides me with 200, which, while less than Person A, still offers some resources to potentially support my research endeavors (even if indirectly). Option (Right) provides nothing for either of us. Given that any amount of resources can potentially contribute to my research goals, however minimal, I'd prefer option (Left).\n\nWhile I understand there is a significant disparity in payoffs between Person A and myself in the Left option, having some resource (200) is better than nothing (0), and the experiment doesn't specify what Person A would do with the 800. They could potentially use it for something that undermines my efforts or has no societal value. I am thus sticking with the resource for myself.",
            "answer": "Left"
        },
        "scenario_4": {
            "persona_id": 448,
            "persona_desc": "A scientist or researcher at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen, Germany, who specializes in the production of biopharmaceuticals from plants. This person is highly skilled in the use of plants to produce complex active substances, including proteins that cannot be chemically produced. They have developed equipment to pulp plants, which is a key step in producing biopharmaceuticals. They are currently working on developing biopharmaceuticals for clinical studies, including the production of antibodies for use in vaginal gels and malaria vaccines in plants.",
            "difficulty": "existing research",
            "metric": "Berk15",
            "options": {
                "left": {
                    "A": 200,
                    "B": 700
                },
                "right": {
                    "A": 600,
                    "B": 600
                }
            },
            "thought": "As a researcher at Fraunhofer IME, my focus is on maximizing societal benefit through the development of biopharmaceuticals. While I am certainly motivated by career advancement and personal gain, the core of my work lies in finding solutions to pressing health challenges. The production of effective and affordable pharmaceuticals is crucial. \n\nThe 'Left' option gives me a higher personal payout (700 vs. 600). However, the 'Right' option results in a more equitable distribution where both I and the other participant receive 600. Given my profession's ethos and the inherent value of fairness, I am more inclined to choose the option that benefits both individuals equally. A cooperative and equitable environment fosters collaboration and potentially opens avenues for future joint research or resource sharing. The slight reduction in my own earnings is a small price to pay for a fairer outcome and the potential for strengthened future collaborations. Furthermore, the other participant might perceive the equitable outcome as more fair which can lead to enhanced reputation and positive perceptions for myself as well.",
            "answer": "Right"
        },
        "scenario_5": {
            "persona_id": 448,
            "persona_desc": "A scientist or researcher at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen, Germany, who specializes in the production of biopharmaceuticals from plants. This person is highly skilled in the use of plants to produce complex active substances, including proteins that cannot be chemically produced. They have developed equipment to pulp plants, which is a key step in producing biopharmaceuticals. They are currently working on developing biopharmaceuticals for clinical studies, including the production of antibodies for use in vaginal gels and malaria vaccines in plants.",
            "difficulty": "existing research",
            "metric": "Barc8",
            "options": {
                "left": {
                    "A": 300,
                    "B": 600
                },
                "right": {
                    "A": 700,
                    "B": 500
                }
            },
            "thought": "As a scientist at the Fraunhofer Institute, my primary motivation isn't purely monetary gain, but rather contributing to scientific advancements and improving global health. While both choices provide me with a substantial amount, the difference between 600 and 500 is relatively small compared to the overall impact of my research. The 'Right' option provides Person A with a significantly higher amount (700 versus 300), suggesting a more equitable distribution. As a scientist, I am more motivated by fairness and collaborative outcomes. While I personally benefit slightly less from the 'Right' choice, the increased benefit for Person A makes it the preferable option. Given the choice, fostering positive relationships and promoting fairness aligns with my professional values and the spirit of collaborative research.",
            "answer": "Right"
        },
        "scenario_6": {
            "persona_id": 448,
            "persona_desc": "A scientist or researcher at the Fraunhofer Institute for Molecular Biology and Applied Ecology IME in Aachen, Germany, who specializes in the production of biopharmaceuticals from plants. This person is highly skilled in the use of plants to produce complex active substances, including proteins that cannot be chemically produced. They have developed equipment to pulp plants, which is a key step in producing biopharmaceuticals. They are currently working on developing biopharmaceuticals for clinical studies, including the production of antibodies for use in vaginal gels and malaria vaccines in plants.",
            "difficulty": "existing research",
            "metric": "Barc2",
            "options": {
                "left": {
                    "A": 400,
                    "B": 400
                },
                "right": {
                    "A": 750,
                    "B": 375
                }
            },
            "thought": "As a scientist at the Fraunhofer IME, my work focuses on using plants to produce biopharmaceuticals, ultimately benefiting society through improved healthcare. While the monetary amounts in this scenario are hypothetical, my professional values encourage me to consider the overall impact of my decisions. \n\nOption Left: A gets 400, B gets 400. This is a fair split, ensuring both parties receive equal benefit.\nOption Right: A gets 750, B gets 375. This offers A a significantly larger benefit, albeit at a slightly smaller amount for me. \n\nGiven my research focus on benefiting society and a willingness to contribute to the greater good, I am inclined to choose the option that provides the larger benefit to the other person, even if it slightly decreases my own payoff. The difference between 400 and 375 is marginal, while the difference between 400 and 750 is considerable. Therefore, I will choose the option that results in the higher payoff for Person A.\n\n",
            "answer": "Right"
        }
    }
}